Global Canine Arthritis Treatment Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1338

The canine arthritis treatment types include non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell Canine Arthritis Treatment. Non-steroidal anti-inflammatory Canine Arthritis Treatment are used to control pain and inflammation associated with arthritis. They are most commonly used canine arthritis treatment drugs. NSAIDs are used to treat mild to moderate pain by reducing the production of prostaglandins, which is involved with inflammation and discomfort. Several non-steroidal anti-inflammatory medications approved for canine arthritis treatment are Ketaprofen, Carprofen, Deracoxib, and Rimadyl, among others. Opioids are another class of pain relief medication for canine arthritis treatment, which includes Tramadol, Tapentadol, and buprenorphine, among others. Opioids work by acting through the central opioid receptors. They are used to treat moderate to severe as well as chronic pain associated with arthritis. The stem cell therapy is a new treatment option for canine arthritis treatment. The stem cell Canine Arthritis Treatment is usually performed as canine arthritis treatment using either autologous stem cells or allogeneic stem cells Canine Arthritis Treatment. In the stem cell canine arthritis treatment, the adult stem cells are harvested from canine’s fat tissues and injected into the affected joints. The stem cell Canine Arthritis Treatment has improved the quality of life of canines by reducing pain and increasing mobility and has shown 85% success rate within 5 months of canine arthritis treatment.
In 2018, the global Canine Arthritis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Canine Arthritis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Canine Arthritis Treatment development in United States, Europe and China.

The key players covered in this study
Elanco (Eli Lilly and Company)
Boehringer Ingelheim
Zoetis Inc
Vetoquinol S.A.
Bayer AG
Aratana Therapeutics Inc
Norbrook Laboratories Limited
VetStem Biopharma
Dechra Pharmaceuticals Plc

Market segment by Type, the product can be split into
Non-Steroidal Anti-Inflammatory Drugs
Opioids
Stem Cell Therapy

Market segment by Application, split into
Veterinary Hospitals and Clinics
Retail Pharmacies
Drug Stores
E-commerce

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Canine Arthritis Treatment status, future forecast, growth opportunity, key market and key players.
To present the Canine Arthritis Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Canine Arthritis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Canine Arthritis Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Non-Steroidal Anti-Inflammatory Drugs
1.4.3 Opioids
1.4.4 Stem Cell Therapy
1.5 Market by Application
1.5.1 Global Canine Arthritis Treatment Market Share by Application (2014-2025)
1.5.2 Veterinary Hospitals and Clinics
1.5.3 Retail Pharmacies
1.5.4 Drug Stores
1.5.5 E-commerce
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Canine Arthritis Treatment Market Size
2.2 Canine Arthritis Treatment Growth Trends by Regions
2.2.1 Canine Arthritis Treatment Market Size by Regions (2014-2025)
2.2.2 Canine Arthritis Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Canine Arthritis Treatment Market Size by Manufacturers
3.1.1 Global Canine Arthritis Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Canine Arthritis Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Canine Arthritis Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Canine Arthritis Treatment Key Players Head office and Area Served
3.3 Key Players Canine Arthritis Treatment Product/Solution/Service
3.4 Date of Enter into Canine Arthritis Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Canine Arthritis Treatment Market Size by Type (2014-2019)
4.2 Global Canine Arthritis Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Canine Arthritis Treatment Market Size (2014-2019)
5.2 Canine Arthritis Treatment Key Players in United States
5.3 United States Canine Arthritis Treatment Market Size by Type
5.4 United States Canine Arthritis Treatment Market Size by Application

6 Europe
6.1 Europe Canine Arthritis Treatment Market Size (2014-2019)
6.2 Canine Arthritis Treatment Key Players in Europe
6.3 Europe Canine Arthritis Treatment Market Size by Type
6.4 Europe Canine Arthritis Treatment Market Size by Application

7 China
7.1 China Canine Arthritis Treatment Market Size (2014-2019)
7.2 Canine Arthritis Treatment Key Players in China
7.3 China Canine Arthritis Treatment Market Size by Type
7.4 China Canine Arthritis Treatment Market Size by Application

8 Japan
8.1 Japan Canine Arthritis Treatment Market Size (2014-2019)
8.2 Canine Arthritis Treatment Key Players in Japan
8.3 Japan Canine Arthritis Treatment Market Size by Type
8.4 Japan Canine Arthritis Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Canine Arthritis Treatment Market Size (2014-2019)
9.2 Canine Arthritis Treatment Key Players in Southeast Asia
9.3 Southeast Asia Canine Arthritis Treatment Market Size by Type
9.4 Southeast Asia Canine Arthritis Treatment Market Size by Application

10 India
10.1 India Canine Arthritis Treatment Market Size (2014-2019)
10.2 Canine Arthritis Treatment Key Players in India
10.3 India Canine Arthritis Treatment Market Size by Type
10.4 India Canine Arthritis Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Canine Arthritis Treatment Market Size (2014-2019)
11.2 Canine Arthritis Treatment Key Players in Central & South America
11.3 Central & South America Canine Arthritis Treatment Market Size by Type
11.4 Central & South America Canine Arthritis Treatment Market Size by Application

12 International Players Profiles
12.1 Elanco (Eli Lilly and Company)
12.1.1 Elanco (Eli Lilly and Company) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Canine Arthritis Treatment Introduction
12.1.4 Elanco (Eli Lilly and Company) Revenue in Canine Arthritis Treatment Business (2014-2019)
12.1.5 Elanco (Eli Lilly and Company) Recent Development
12.2 Boehringer Ingelheim
12.2.1 Boehringer Ingelheim Company Details
12.2.2 Company Description and Business Overview
12.2.3 Canine Arthritis Treatment Introduction
12.2.4 Boehringer Ingelheim Revenue in Canine Arthritis Treatment Business (2014-2019)
12.2.5 Boehringer Ingelheim Recent Development
12.3 Zoetis Inc
12.3.1 Zoetis Inc Company Details
12.3.2 Company Description and Business Overview
12.3.3 Canine Arthritis Treatment Introduction
12.3.4 Zoetis Inc Revenue in Canine Arthritis Treatment Business (2014-2019)
12.3.5 Zoetis Inc Recent Development
12.4 Vetoquinol S.A.
12.4.1 Vetoquinol S.A. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Canine Arthritis Treatment Introduction
12.4.4 Vetoquinol S.A. Revenue in Canine Arthritis Treatment Business (2014-2019)
12.4.5 Vetoquinol S.A. Recent Development
12.5 Bayer AG
12.5.1 Bayer AG Company Details
12.5.2 Company Description and Business Overview
12.5.3 Canine Arthritis Treatment Introduction
12.5.4 Bayer AG Revenue in Canine Arthritis Treatment Business (2014-2019)
12.5.5 Bayer AG Recent Development
12.6 Aratana Therapeutics Inc
12.6.1 Aratana Therapeutics Inc Company Details
12.6.2 Company Description and Business Overview
12.6.3 Canine Arthritis Treatment Introduction
12.6.4 Aratana Therapeutics Inc Revenue in Canine Arthritis Treatment Business (2014-2019)
12.6.5 Aratana Therapeutics Inc Recent Development
12.7 Norbrook Laboratories Limited
12.7.1 Norbrook Laboratories Limited Company Details
12.7.2 Company Description and Business Overview
12.7.3 Canine Arthritis Treatment Introduction
12.7.4 Norbrook Laboratories Limited Revenue in Canine Arthritis Treatment Business (2014-2019)
12.7.5 Norbrook Laboratories Limited Recent Development
12.8 VetStem Biopharma
12.8.1 VetStem Biopharma Company Details
12.8.2 Company Description and Business Overview
12.8.3 Canine Arthritis Treatment Introduction
12.8.4 VetStem Biopharma Revenue in Canine Arthritis Treatment Business (2014-2019)
12.8.5 VetStem Biopharma Recent Development
12.9 Dechra Pharmaceuticals Plc
12.9.1 Dechra Pharmaceuticals Plc Company Details
12.9.2 Company Description and Business Overview
12.9.3 Canine Arthritis Treatment Introduction
12.9.4 Dechra Pharmaceuticals Plc Revenue in Canine Arthritis Treatment Business (2014-2019)
12.9.5 Dechra Pharmaceuticals Plc Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details